4-Hydroxyisoleucine: A plant-derived treatment for metabolic syndrome

Current Opinion in Investigational Drugs

Volumn 10, Issue 4, 2009, Pages 353-358

  Jetté, Lucie ^a   Harvey, Laurent ^a   Eugeni, Karen ^b   Levens, Nigel ^a  

^a BELLUS Health Inc   (Canada)

^b Diabesity Digest   (Canada)

Author keywords

4 Hydroxyisoleucine; Dyslipidemia; Glucose; Insulin; Obesity; Type 2 diabetes

Indexed keywords

4 HYDROXYISOLEUCINE; GLUCOSE; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE;

DYSLIPIDEMIA; ENZYME ACTIVITY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; STREPTOZOCIN DIABETES;

ANIMALS; ANTI-OBESITY AGENTS; ANTILIPEMIC AGENTS; ENERGY METABOLISM; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISOLEUCINE; LIPID METABOLISM; METABOLIC SYNDROME X; PHYTOTHERAPY; PLANT PREPARATIONS; TRIGONELLA;

EID: 63849095796     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Petropoulos GA (Ed): Fenugreek: The Genus of Trigonella. Taylor and Francis Inc, New York, NY, USA (2002).
2. Nazza G, Oomah BD (Eds): Herbs, Botanicals and Teas. Woodhead Publishing Ltd, Cambridge, UK (2000).
3. Miller JI: The Spice Trade of the Roman Empire 29 BC to AD 641. Oxford University Press (Clarendon Press), Oxford, UK (1969).
4. Andrews P, Hough L, Jones KN: Mannose-containing polysaccharide, part 2. The galactomannan of fenugreek seed (Trigonella Foenum-graecum). Chem Soc (1952) 74(16):2744-2750.
5. Sharma RD: Effect of fenugreek seeds and leaves on blood glucose and serum insulin responses in human objects. Nutrition Res (1986) 6(12):1353-1364.
6. Valette G, Sauvaire Y, Baccou JC, Ribes G: Hypochlolesterolemic effect of fenugreek seeds in dogs. Atherosclerosis (1984) 50(1):105-111.
7. Ribs G, Sauvaire Y, Da Costa C, Baccou JC, Loubatieres-Mariani MM: Antidiabetic effects of subfractions from fenugreek seeds in diabetic dogs. Proc Soc Exp Biol Med (1986) 182(2):159-166.
8. Madar Z, Shomer I: Polysaccharide composition of a gel fraction derived from fenugreek and its effect on starch digestion and bile acid absorption in rats. J Agricult Food Chem (1990) 38(7):1535-1539.
9. Fowden L, Pratt HM, Smith A: 4-Hydroxyisoleucine from seed of Trigonella foenum-graecum. Phytochemistry (1973) 12(7):1707-1711.
10. Sauvaire Y, Girardon P, Baccou JC, Ristérucci AM: Changes in growth, proteins and free amino acids of developing seed and pod of fenugreek. Phytochemistry (1984) 23(3):479-486.
11. Mosihuzzaman M, Azad Khan AK, Ali L: Effect of soluble dietary fibre fraction of Trigonella foenum graecum on glycemic, insulinemic, lipidemic and platelet aggregation status of type 2 diabetic model rats. J Ethnopharmacol (2003) 88(1):73-77.
12. Puri D: Therapeutic potentials of fenugreek. Indian J Physiol Pharmacol (1998) 42(3):423-424.
13. Handa T, Yamaguchi K, Sono Y, Yazawa K: Effects of fenugreek seed extract in obese mice fed a high-fat diet. Biosci Biotechnol Biochem (2005) 69(6):1186-1188.
14. Ruby BC, Gaskill SE, Slivka D, Harger SG: The addition of fenugreek extract (Trigonella foenum-graecum) to glucose feeding increases muscle glycogen resynthesis after exercise. Amino Acids (2005) 28(1):71-76.
15. Hannan JM, Ali L, Rokeya B, Khaleque J, Akhter M, Flatt PR, Abdel-Wahab YH: Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr (2007) 97(3):514-521.
16. Zia T, Hasnain SN, Hasan SK: Evaluation of the oral hypoglycaemic effect of Trigonella foenum-graecum L (methi) in normal mice. J Ethnopharmacol (2001) 75(2-3):191-195.
17. Ikeuchi M, Yamaguchi K, Koyama T, Sono Y, Yazawa K: Effects of fenugreek seeds (Trigonella foenum greaecum) extract on endurance capacity in mice. J Nutr Sci Vitaminol (2006) 52(4):287-292.
18. Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ: Trigonellafoenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem (2001) 224(1-2):45-51.
19. Xue WL, Li XS, Zhang J, Liu YH, Wang ZL, Zhang RJ: Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr (2007) 16(Suppl 1):422-426.
20. Sauvaire Y, Petit P, Broca C, Manteghetti M, Baissac Y, Fernandez-Alvarez J, Gross R, Roye M, Leconte A, Gomis R, Ribes G: 4-Hydroxyisoleucine: A novel amino acid potentiator of insulin secretion. Diabetes (1998) 47(2):206-210.
21. Broca C, Breil V, Cruciani-Guglielmacci C, Manteghetti M, Rouault C, Derouet M, Rizkalla S, Pau B, Petit P, Ribes G, Ktorza At al: Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Am J Physiol Endocrinol Metab (2004) 287(3):E463-E471.
22. Broca C, Manteghetti M, Gross R, Baissac Y, Jacob M, Petit P, Sauvaire Y, Ribes G: 4-Hydroxyisoleucine: Effects of synthetic and natural analogs on insulin secretion. Eur J Pharmacol (2000) 390(3):339-345.
23. Broca C, Gross R, Petit P, Sauvaire Y, Manteghetti M, Tournier M, Masiello P, Gomis R, Ribes G: 4-Hydroxyisoleucine: Experimental evidence of its insulinotropic and antidiabetic properties. Am J Physiol (1999) 277(4 Pt 1):E617-E623.
24. Haeri MR, Izaddoost M, Ardekani MR, Nobar MR, White KN: The effect of fenugreek 4-hydroxyisoleucine on liver function biomarkers and glucose in diabetic and fructose-fed rats. Phytother Res (2009) 23(1):61-64.
25. Kahn CR: Insulin receptors and insulin signaling in normal and disease states. In: International Textbook of Diabetes Mellitus. Alberti KGMM, Zimmet P, DeFronzo RA, Keen H (Eds), Lippincott-Raven, Philadelphia, PA, USA (1997):437-467.
26. Narender T, Puri A, Shweta PA, Khaliq T, Saxena R, Bhatia G, Chandra R: 4-hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent. Bioorg Med Chem Lett (2006) 16(2):293-296.
27. Knopp RH , Retzlaff B, Aikawa K, Kahn SE: Management of patients with diabetic hyperlipidemia. Am J Cardiol (2003) 91(7A):24E-28E.
28. Westerterp KR: Diet-induced thermogenesis. Nutr Metab (2004) 1(1):5.
29. Leidy HJ, Mattes RD, Campbell WW: Effects of acute and chronic protein intake on metabolism, appetite and ghrelin during weight loss. Obesity (2007) 15(5):1215-1225.
30. Clifton PM, Keogh J: Metabolic effects of high-protein diets. Curr Atheroscler Rep (2007) 9(6):472-478.
31. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, Hutson SM: Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab (2007) 6(3):181-194. A key study demonstrating that leucine injection into the brain influenced food intake.
32. Ropelle ER, Pauli JR, Fernandes MF, Rocco SA, Marin RM, Morari J, Souza KK, Dias MM, Gomes-Marcondes MC, Gontijo JA, Franchini KG et al: A central role for neuronal AMPactivated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss. Diabetes (2008) 57(3):594-605.
33. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ: Hypothalamic mTOR signaling regulates food intake. Science (2006) 312(5775):927-930.
34. Lynch CJ, Gern B, Lloyd C, Hutson SM, Eicher R, Vary TC: Leucine in food mediates some of the postprandial rise in plasma leptin concentrations. Am J Physiol Endocrinol Metab (2006) 291(3):E621-E630.
35. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, Hutson SM: Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab (2007) 6(3):181-194.
36. Kehara O, Kawasaki N, Maezono K, Komatsu M, Konishi A: Acute and chronic treatment of l-isoleucine ameliorates glucose metabolism in glucose-intolerant and diabetic mice. Biol Pharm Bull (2008) 31(3):469-472.
37. Doi M, Yamaoka I, Nakayama M, Sugahara K, Yoshizawa F: Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. Am J Physiol Endocrinol Metab (2007) 292(6):E1683-E1693.
38. Doi M, Yamaoka I, Fukunaga T, Nakayama M: Isoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes. Biochem Biophys Res Commun (2003) 312(4):1111-1117.